JENNY MCKAY: Open Payments
NPI 1295256543 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,122 in 87 payments from 26 companies in 2025. Trend: 2023 $923 · 2024 $1,390 · 2025 $2,122
Food & beverage: $2,122
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $507 |
| Corcept Therapeutics | 9 | $313 |
| AstraZeneca Pharmaceuticals LP | 6 | $204 |
| Janssen Pharmaceuticals, Inc | 3 | $160 |
| Axsome Therapeutics, Inc. | 4 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $119 |
| Novo Nordisk Inc | 2 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Indivior Inc. | 3 | $60 |
| Alkermes, Inc. | 2 | $52 |
Products named: VRAYLAR, Korlym, SPRAVATO, Auvelity, BREZTRI, CAPLYTA, REXULTI, Wegovy.
Industry payments across UT — which companies pay providers there.
